Concepedia

Author

David E. Lanar

Walter Reed Army Institute of Research

Also Known As

D E Lanar, D LANAR, D Lanar, D. E. Lanar, D. Lanar, D.E Lanar, D.E. Lanar, DAVID E. LANAR, David E Lanar, David E. LANAR

119

Publications

7.6K

Citations

51

H-Index

101

Concepts

All Affiliations

Walter Reed Army Institute of ResearchKenya Medical Research InstituteNational Institute of Allergy and Infectious DiseasesUniversity of ConnecticutNational Institutes of Health
DE

About

David E. Lanar is an author at Walter Reed Army Institute of Research specializing in medicine, immunology, and malaria.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

30

49

3K

2

Natural Sciences

11

11

774

3

Engineering

3

3

71

4

Health Sciences

2

2

79

5

Public Health

2

2

186

David E. Lanar

×

97

Publications

7.4K

Citations

50

H-Index

YearCitations

Breadth and Magnitude of Antibody Responses to Multiple <i>Plasmodium falciparum</i> Merozoite Antigens Are Associated with Protection from Clinical Malaria

Faith Osier, Greg Fegan, Spencer D. Polley,

Infection and Immunity

2008

388

A Field Trial to Assess a Blood-Stage Malaria Vaccine

Mahamadou A. Théra, Ogobara K. Doumbo, Drissa Coulibaly,

New England Journal of Medicine

2011

358

Circumsporozoite Protein Heterogeneity in the Human Malaria Parasite <i>Plasmodium vivax</i>

Ronald Rosenberg, Robert A. Wirtz, David E. Lanar,

Science

1989

256

Long‐Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

José A. Stoute, Kent E. Kester, Urszula Krzych,

The Journal of Infectious Diseases

1998

235

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.

Edward J. Pearce, Stephanie L. James, Sara Hieny,

Proceedings of the National Academy of Sciences

1988

225

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

Michele Spring, James F. Cummings, Christian F. Ockenhouse,

PLoS ONE

2009

207

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria

Spencer D. Polley, Tabitha Mwangi, Clemens H. M. Kocken,

Vaccine

2004

201

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life

Samson Kinyanjui, David J. Conway, David E. Lanar,

Malaria Journal

2007

191

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum

Alison Roth, Steven P. Maher, Amy J. Conway,

Nature Communications

2018

190

Duration of Naturally Acquired Antibody Responses to Blood-Stage<i>Plasmodium falciparum</i>Is Age Dependent and Antigen Specific

Onome Akpogheneta, Nancy Odurowah Duah-Quashie, Kevin K. A. Tetteh,

Infection and Immunity

2008

178

Page 1